Chinook Therapeutics
KDNY
#4185
Rank
NZ$4.70 B
Marketcap
NZ$70.13
Share price
0.00%
Change (1 day)
102.62%
Change (1 year)

Revenue for Chinook Therapeutics (KDNY)

Revenue in 2023 (TTM): NZ$9.8 Million

According to Chinook Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$10.15 Million. In 2022 the company made a revenue of NZ$9.65 Million a decrease over the revenue in the year 2021 that were of NZ$75.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Chinook Therapeutics from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$9.8 M1.59%
2022 NZ$9.65 M-87.23%
2021 NZ$75.58 M1081.94%
2020 NZ$6.39 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA